All News about Vir Biotechnology Inc
![](https://mms.businesswire.com/media/20240718400254/en/1895639/22/VIR_logo_large_color.jpg)
![](https://investorplace.com/wp-content/uploads/2021/03/biotech-stocks-2.jpg)
![](https://mms.businesswire.com/media/20240626614229/en/1895639/22/VIR_logo_large_color.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/06/05/VIR.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_3.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2024/06/05/xrdDAFtH5xd8iU2-j4016486423666345323-t23.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/06/05/xrdDAFeBN6UDDA2-j43848844441-t23032312.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.jpeg?width=1200&height=800&fit=crop)
Recap: Vir Biotechnology Q4 Earnings
February 22, 2024
Via Benzinga
![](https://mms.businesswire.com/media/20240605189185/en/1895639/22/VIR_logo_large_color.jpg)
![](https://mms.businesswire.com/media/20240529942722/en/1895639/22/VIR_logo_large_color.jpg)
![](https://mms.businesswire.com/media/20240529079100/en/1895639/22/VIR_logo_large_color.jpg)
![](https://mms.businesswire.com/media/20240523355863/en/1895639/22/VIR_logo_large_color.jpg)
![](https://mms.businesswire.com/media/20240522281167/en/1895639/22/VIR_logo_large_color.jpg)
![](https://mms.businesswire.com/media/20240516732892/en/1895639/22/VIR_logo_large_color.jpg)
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://mms.businesswire.com/media/20240502260564/en/1895639/22/VIR_logo_large_color.jpg)
![](https://mms.businesswire.com/media/20240430254007/en/1895639/22/VIR_logo_large_color.jpg)
![](https://mms.businesswire.com/media/20240418098064/en/1895639/22/VIR_logo_large_color.jpg)
![](https://mms.businesswire.com/media/20240411706041/en/1895639/22/VIR_logo_large_color.jpg)
![](https://investorplace.com/wp-content/uploads/2021/03/biotech-stocks-2.jpg)
![](https://investorplace.com/wp-content/uploads/2019/11/bill-gates.jpg)
![](https://mms.businesswire.com/media/20240305632917/en/1895639/22/VIR_logo_large_color.jpg)
![](https://investorplace.com/wp-content/uploads/2022/10/droplet-test-tube-biotech-1600-3.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/02/23/image21.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/02/23/image32_0.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20240220184688/en/1895639/22/VIR_logo_large_color.jpg)
Via Business Wire
![](https://mms.businesswire.com/media/20240222740501/en/1895639/22/VIR_logo_large_color.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.